» Articles » PMID: 20046678

Clinical Grade Adult Stem Cell Banking

Overview
Journal Organogenesis
Date 2010 Jan 5
PMID 20046678
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

There has been a great deal of scientific interest recently generated by the potential therapeutic applications of adult stem cells in human care but there are several challenges regarding quality and safety in clinical applications and a number of these challenges relate to the processing and banking of these cells ex-vivo. As the number of clinical trials and the variety of adult cells used in regenerative therapy increases, safety remains a primary concern. This has inspired many nations to formulate guidelines and standards for the quality of stem cell collection, processing, testing, banking, packaging and distribution. Clinically applicable cryopreservation and banking of adult stem cells offers unique opportunities to advance the potential uses and widespread implementation of these cells in clinical applications. Most current cryopreservation protocols include animal serum proteins and potentially toxic cryoprotectant additives (CPAs) that prevent direct use of these cells in human therapeutic applications. Long term cryopreservation of adult stem cells under good manufacturing conditions using animal product free solutions is critical to the widespread clinical implementation of ex-vivo adult stem cell therapies. Furthermore, to avoid any potential cryoprotectant related complications, reduced CPA concentrations and efficient post-thaw washing to remove CPA are also desirable. The present review focuses on the current strategies and important aspects of adult stem cell banking for clinical applications. These include current good manufacturing practices (cGMPs), animal protein free freezing solutions, cryoprotectants, freezing & thawing protocols, viability assays, packaging and distribution. The importance and benefits of banking clinical grade adult stem cells are also discussed.

Citing Articles

Autologous hGMSC-Derived iPS: A New Proposal for Tissue Regeneration.

Della Rocca Y, Diomede F, Konstantinidou F, Gatta V, Stuppia L, Benedetto U Int J Mol Sci. 2024; 25(17).

PMID: 39273117 PMC: 11395260. DOI: 10.3390/ijms25179169.


Good manufacturing practices production of human placental derived mesenchymal stem cells for therapeutic applications: focus on multiple sclerosis.

Shokati A, Naser Moghadasi A, Ghashghaei A, Sahraian M, Chahardouli B, Mousavi S Mol Biol Rep. 2024; 51(1):460.

PMID: 38551770 DOI: 10.1007/s11033-024-09372-1.


Effect of an low-energy Nd: YAG laser on periodontal ligament stem cell homing through the SDF-1/CXCR4 signaling pathway.

Wu N, Song J, Liu X, Ma X, Guo X, Liu T BMC Oral Health. 2023; 23(1):501.

PMID: 37468947 PMC: 10357748. DOI: 10.1186/s12903-023-03132-6.


Industrial Biotechnology Conservation Processes: Similarities with Natural Long-Term Preservation of Biological Organisms.

Laurent A, Scaletta C, Abdel-Sayed P, Raffoul W, Hirt-Burri N, Applegate L BioTech (Basel). 2023; 12(1).

PMID: 36810442 PMC: 9944097. DOI: 10.3390/biotech12010015.


Rapid and Continuous Cryopreservation of Stem Cells with a 3D Micromixer.

Ding L, Razavi Bazaz S, Shrestha J, Amiri H, Mas-Hafi S, Banerjee B Micromachines (Basel). 2022; 13(9).

PMID: 36144139 PMC: 9500807. DOI: 10.3390/mi13091516.


References
1.
Windrum P, Morris T, Drake M, Niederwieser D, Ruutu T . Variation in dimethyl sulfoxide use in stem cell transplantation: a survey of EBMT centres. Bone Marrow Transplant. 2005; 36(7):601-3. DOI: 10.1038/sj.bmt.1705100. View

2.
de Boer F, Drager A, Pinedo H, Kessler F, van der Wall E, Jonkhoff A . Extensive early apoptosis in frozen-thawed CD34-positive stem cells decreases threshold doses for haematological recovery after autologous peripheral blood progenitor cell transplantation. Bone Marrow Transplant. 2002; 29(3):249-55. DOI: 10.1038/sj.bmt.1703357. View

3.
Kern S, Eichler H, Stoeve J, Kluter H, Bieback K . Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells. 2006; 24(5):1294-301. DOI: 10.1634/stemcells.2005-0342. View

4.
Chan C, McCulley S, Macmillan R . Autologous fat transfer--a review of the literature with a focus on breast cancer surgery. J Plast Reconstr Aesthet Surg. 2008; 61(12):1438-48. DOI: 10.1016/j.bjps.2008.08.006. View

5.
Benekli M, Anderson B, Wentling D, Bernstein S, Czuczman M, McCarthy P . Severe respiratory depression after dimethylsulphoxide-containing autologous stem cell infusion in a patient with AL amyloidosis. Bone Marrow Transplant. 2000; 25(12):1299-301. DOI: 10.1038/sj.bmt.1702452. View